|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02192 MEDLIVE
Nominal 
8.990 +0.040 (+0.447%) Ranking Overview
Ranking based on 3 research report(s)
Average Ranking 2.33
|
Strong Buy (1)
0
|
Buy (2)
2
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 43.23 RMB (cts) | |
| Net Profit | 315.15 RMB (MIL) | DPS | 25.71 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 320.00 | 43.90 | 25.13 | -- | 322.30 | 316.30 |
| 2026 | 362.50 | 50.00 | 27.32 | -- | 364.12 | 328.00 |
| 2027 | 422.90 | 58.00 | 29.86 | -- | 426.01 | 334.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 322.30 | 44.00 | -- | CHINA SEC INT'L BRO | Buy | 16.80 | (6M) | 23/09/2025 |
| 2025 | 316.30 | 43.90 | 26.25 | UOB | Buy | 13.50 | 25/02/2026 | |
| 2025 | 320.00 | 43.00 | 24.00 | HSBC | Hold | 12.70 | 27/01/2026 | |
| 2026 | 364.12 | 50.00 | -- | CHINA SEC INT'L BRO | - | -- | 23/09/2025 | |
| 2026 | 362.50 | 50.00 | 29.63 | UOB | - | -- | 25/02/2026 | |
| 2026 | 328.00 | 44.00 | 25.00 | HSBC | - | -- | 27/01/2026 | |
| 2027 | 426.01 | 58.00 | -- | CHINA SEC INT'L BRO | - | -- | 23/09/2025 | |
| 2027 | 422.90 | 58.20 | 34.71 | UOB | - | -- | 25/02/2026 | |
| 2027 | 334.00 | 45.00 | 25.00 | HSBC | - | -- | 27/01/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 27/02/2026 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 155,338 |
| %Change | 5.874% |
| EPS / (LPS) | RMB 0.212 |
| NBV Per Share (¥) | RMB 6.603 |